Skip to main content
Erschienen in: Annals of Surgical Oncology 6/2014

01.06.2014 | Gastrointestinal Oncology

Follow-Up After Gastrectomy for Cancer: An Appraisal of the Italian Research Group for Gastric Cancer

verfasst von: Gian Luca Baiocchi, MD, Daniele Marrelli, MD, Giuseppe Verlato, MD, Paolo Morgagni, MD, Simone Giacopuzzi, MD, Arianna Coniglio, MD, Alberto Marchet, MD, Fausto Rosa, MD, Michela Giulii Capponi, MD, Alberto Di Leo, MD, Luca Saragoni, MD, Luca Ansaloni, MD, Fabio Pacelli, MD, Donato Nitti, MD, Domenico D’Ugo, MD, Franco Roviello, MD, Guido A. M. Tiberio, MD, Stefano M. Giulini, MD, Giovanni De Manzoni, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

The Italian Research Group for Gastric Cancer supports the practice of follow-up after radical surgery for gastric cancer.

Methods

This multicenter, retrospective study (1998–2009) included patients with T1-4N0-3M0 gastric cancer who had undergone D2 gastrectomy and lymphadenectomy, with at least 15 lymph nodes examined, and who had developed recurrent disease. Timing and site of recurrence were correlated to the actual scheduled follow-up timing and modalities.

Results

From eight centers, 814 patients with recurrent cancer and over 1,754 (46.4 %) patients undergoing gastrectomy were investigated (median follow-up 31 months). The most frequent sites of recurrence were local/regional lymph nodes (35.4 %), liver (24.3 %), peritoneum (30.3 %), lung (10.4 %) and intraluminal (7.5 %). Ninety-four percent of the recurrences were diagnosed within 2 years and 98 % within 3 years. Thoracoabdominal computed tomography (CT) scan and (18)F-fluoro-2-deoxy-d-glucose positron emission tomography (18-FDG-PET) detected more than 90 % of recurrences, abdominal ultrasound detected 70 % and tumor markers detected 40 %, while <10 % were identified by physical examination, chest X-ray, and upper gastrointestinal endoscopy. Twenty-six percent of patients with recurrence were treated, but only 3.2 % were treated with potentially radical intent.

Conclusion

Oncological follow-up after radical surgery for gastric cancer should be focused in the first 3 years, and based mainly on thoracoabdominal CT scan and 18-FDG-PET.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Roviello F, Marrelli D, de Manzoni G, et al. Prospective study of peritoneal recurrence after curative surgery for gastric cancer. Br J Surg. 2003;90:1113–9.PubMedCrossRef Roviello F, Marrelli D, de Manzoni G, et al. Prospective study of peritoneal recurrence after curative surgery for gastric cancer. Br J Surg. 2003;90:1113–9.PubMedCrossRef
2.
Zurück zum Zitat Shiraishi N, Inomata M, Osawa N, Yasuda K, Adachi Y, Kitano S. Early and late recurrence after gastrectomy for gastric carcinoma: univariate and multivariate analyses. Cancer. 2000;89:255–61.PubMedCrossRef Shiraishi N, Inomata M, Osawa N, Yasuda K, Adachi Y, Kitano S. Early and late recurrence after gastrectomy for gastric carcinoma: univariate and multivariate analyses. Cancer. 2000;89:255–61.PubMedCrossRef
3.
Zurück zum Zitat Schwarz RE, Zagala-Nevarez K. Recurrence patterns after radical gastrectomy for gastric cancer: prognostic factors and implications for postoperative adjuvant therapy. Ann Surg Oncol. 2002;9:394–400.PubMedCrossRef Schwarz RE, Zagala-Nevarez K. Recurrence patterns after radical gastrectomy for gastric cancer: prognostic factors and implications for postoperative adjuvant therapy. Ann Surg Oncol. 2002;9:394–400.PubMedCrossRef
4.
Zurück zum Zitat Baiocchi GL, Tiberio G, Minicozzi A, et al. A multicentric western analysis of prognostic factors in advanced, node-negative gastric cancer patients. Ann Surg. 2010;252:70–3.PubMedCrossRef Baiocchi GL, Tiberio G, Minicozzi A, et al. A multicentric western analysis of prognostic factors in advanced, node-negative gastric cancer patients. Ann Surg. 2010;252:70–3.PubMedCrossRef
5.
Zurück zum Zitat Marrelli D, Roviello F, de Manzoni G, et al. Different pattern of recurrence in gastric cancer depending on Lauren’s histological type: a longitudinal study. World J Surg. 2002;26:1160–5.PubMedCrossRef Marrelli D, Roviello F, de Manzoni G, et al. Different pattern of recurrence in gastric cancer depending on Lauren’s histological type: a longitudinal study. World J Surg. 2002;26:1160–5.PubMedCrossRef
6.
Zurück zum Zitat Bohner H, Zimmer T, Hopfenmüller W, Berger G, Buhr HJ. Detection and prognosis of recurrent gastric cancer; is routine follow-up after gastrectomy worthwhile? Hepatogastroenterology. 2000;47:1489–94.PubMed Bohner H, Zimmer T, Hopfenmüller W, Berger G, Buhr HJ. Detection and prognosis of recurrent gastric cancer; is routine follow-up after gastrectomy worthwhile? Hepatogastroenterology. 2000;47:1489–94.PubMed
7.
Zurück zum Zitat Eom BW, Ryu KW, Lee JH, et al. Oncologic effectiveness of regular follow-up to detect recurrence after curative resection of gastric cancer. Ann Surg Oncol. 2009;18:358–64.CrossRef Eom BW, Ryu KW, Lee JH, et al. Oncologic effectiveness of regular follow-up to detect recurrence after curative resection of gastric cancer. Ann Surg Oncol. 2009;18:358–64.CrossRef
8.
Zurück zum Zitat Kodera Y, Ito S, Yamamura Y, Mochizuki Y, et al. Follow-up surveillance for recurrence after curative gastric cancer surgery lacks survival benefit. Ann Surg Oncol. 2003;10:898–902.PubMedCrossRef Kodera Y, Ito S, Yamamura Y, Mochizuki Y, et al. Follow-up surveillance for recurrence after curative gastric cancer surgery lacks survival benefit. Ann Surg Oncol. 2003;10:898–902.PubMedCrossRef
9.
Zurück zum Zitat Tan IT, So BY. Value of intensive follow-up of patients after curative surgery for gastric carcinoma. J Surg Oncol. 2007;96:503–6.PubMedCrossRef Tan IT, So BY. Value of intensive follow-up of patients after curative surgery for gastric carcinoma. J Surg Oncol. 2007;96:503–6.PubMedCrossRef
10.
Zurück zum Zitat Villarreal-Garza C, Rojas-Flores M, Castro-Sánchez A, Villa AR, García-Aceituno L, León-Rodríguez E. Improved outcome in asymptomatic recurrence following curative surgery for gastric cancer. Med Oncol. 2011;28:973–80.PubMedCrossRef Villarreal-Garza C, Rojas-Flores M, Castro-Sánchez A, Villa AR, García-Aceituno L, León-Rodríguez E. Improved outcome in asymptomatic recurrence following curative surgery for gastric cancer. Med Oncol. 2011;28:973–80.PubMedCrossRef
11.
Zurück zum Zitat Whiting J, Sano T, Saka M, Fukagawa T, Katai H, Sasako M. Follow-up of gastric cancer: a review. Gastric Cancer. 2006;9:74–81.PubMedCrossRef Whiting J, Sano T, Saka M, Fukagawa T, Katai H, Sasako M. Follow-up of gastric cancer: a review. Gastric Cancer. 2006;9:74–81.PubMedCrossRef
12.
Zurück zum Zitat Verlato G, Roviello F, Marchet A, et al. Indexes of surgical quality in gastric cancer surgery: experience of an Italian network. Ann Surg Oncol. 2009;16:594–602.PubMedCrossRef Verlato G, Roviello F, Marchet A, et al. Indexes of surgical quality in gastric cancer surgery: experience of an Italian network. Ann Surg Oncol. 2009;16:594–602.PubMedCrossRef
13.
Zurück zum Zitat Marrelli D, De Stefano A, de Manzoni G, Morgagni P, Di Leo A, Roviello F. Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter study. Ann Surg. 2005;241:247–255.PubMedCentralPubMedCrossRef Marrelli D, De Stefano A, de Manzoni G, Morgagni P, Di Leo A, Roviello F. Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter study. Ann Surg. 2005;241:247–255.PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat Marrelli D, Caruso S, Roviello F. Follow-up and treatment of recurrence. In: de Manzoni G, Roviello F, Siquini W, editors. Surgery in the multimodal management of gastric cancer. Milan: Springer; 2012. Marrelli D, Caruso S, Roviello F. Follow-up and treatment of recurrence. In: de Manzoni G, Roviello F, Siquini W, editors. Surgery in the multimodal management of gastric cancer. Milan: Springer; 2012.
15.
Zurück zum Zitat Bennett JJ, Gonen M, D’Angelica M, Jaques DP, Brennan MF, Coit DG. Is detection of asymptomatic recurrence after curative resection associated with improved survival in patients with gastric cancer? J Am Coll Surg. 2005;201:503–10.PubMedCrossRef Bennett JJ, Gonen M, D’Angelica M, Jaques DP, Brennan MF, Coit DG. Is detection of asymptomatic recurrence after curative resection associated with improved survival in patients with gastric cancer? J Am Coll Surg. 2005;201:503–10.PubMedCrossRef
16.
Zurück zum Zitat Kim JH, Jang YJ, Park SS, Park SH, Mok YJ. Benefit of post-operative surveillance for recurrence after curative resection for gastric cancer. J Gastrointest Surg. 2010;14:969–76.PubMedCrossRef Kim JH, Jang YJ, Park SS, Park SH, Mok YJ. Benefit of post-operative surveillance for recurrence after curative resection for gastric cancer. J Gastrointest Surg. 2010;14:969–76.PubMedCrossRef
17.
Zurück zum Zitat Hur H, Song KY, Park CH, Jeon HM. Follow-up strategy after curative resection of gastric cancer: a nationwide survey in Korea. Ann Surg Oncol. 2010;17:54–64.PubMedCrossRef Hur H, Song KY, Park CH, Jeon HM. Follow-up strategy after curative resection of gastric cancer: a nationwide survey in Korea. Ann Surg Oncol. 2010;17:54–64.PubMedCrossRef
18.
Zurück zum Zitat Moon YW, Jeung HC, Rha SY, et al. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single Korean institute. Ann Surg Oncol. 2007;14:2730–7.PubMedCrossRef Moon YW, Jeung HC, Rha SY, et al. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single Korean institute. Ann Surg Oncol. 2007;14:2730–7.PubMedCrossRef
19.
Zurück zum Zitat Nashimoto A, Yabusaki H, Nakagawa S. Proper follow-up schedule after curative gastric surgery [in Japanese]. Gan To Kagaku Ryoho. 2009;36:1402–7.PubMed Nashimoto A, Yabusaki H, Nakagawa S. Proper follow-up schedule after curative gastric surgery [in Japanese]. Gan To Kagaku Ryoho. 2009;36:1402–7.PubMed
20.
Zurück zum Zitat Yamamoto M, Yamanaka T, Baba H, Kakeji Y, Maehara Y. The postoperative recurrence and the occurrence of second primary carcinomas in patients with early gastric carcinoma. J Surg Oncol. 2008;97:231–5.PubMedCrossRef Yamamoto M, Yamanaka T, Baba H, Kakeji Y, Maehara Y. The postoperative recurrence and the occurrence of second primary carcinomas in patients with early gastric carcinoma. J Surg Oncol. 2008;97:231–5.PubMedCrossRef
21.
Zurück zum Zitat Sano T, Sasako M, Kinoshita T, Maruyama K. Recurrence of early gastric cancer: follow-up of 1475 patients and review of the Japanese literature. Cancer. 1993;72:3174–8.PubMedCrossRef Sano T, Sasako M, Kinoshita T, Maruyama K. Recurrence of early gastric cancer: follow-up of 1475 patients and review of the Japanese literature. Cancer. 1993;72:3174–8.PubMedCrossRef
22.
Zurück zum Zitat Nashimoto A, Yabusaki H, Nakagawa S. Evaluation and problems of follow-up surveillance after curative gastric cancer surgery. Nihon Geka Gakkai Zasshi. 2007;108:120–4.PubMed Nashimoto A, Yabusaki H, Nakagawa S. Evaluation and problems of follow-up surveillance after curative gastric cancer surgery. Nihon Geka Gakkai Zasshi. 2007;108:120–4.PubMed
23.
Zurück zum Zitat Lee SY, Lee JH, Hwang NC, et al. The role of follow-up endoscopy after total gastrectomy for gastric cancer. Eur J Surg Oncol. 2005;31:265–9.PubMedCrossRef Lee SY, Lee JH, Hwang NC, et al. The role of follow-up endoscopy after total gastrectomy for gastric cancer. Eur J Surg Oncol. 2005;31:265–9.PubMedCrossRef
24.
Zurück zum Zitat Morgagni P, Marfisi C, Gardini A, et al. Subtotal gastrectomy as treatment for distal multifocal early gastric cancer. J Gastrointest Surg. 2009;13:2239–44.PubMedCrossRef Morgagni P, Marfisi C, Gardini A, et al. Subtotal gastrectomy as treatment for distal multifocal early gastric cancer. J Gastrointest Surg. 2009;13:2239–44.PubMedCrossRef
25.
Zurück zum Zitat Marrelli D, Pinto E, De Stefano A, Farnetani M, Garosi L, Roviello F. Clinical utility of CEA, CA 19-9, and CA 72-4 in the follow-up of patients with resectable gastric cancer. Am J Surg. 2001;181:16–9.PubMedCrossRef Marrelli D, Pinto E, De Stefano A, Farnetani M, Garosi L, Roviello F. Clinical utility of CEA, CA 19-9, and CA 72-4 in the follow-up of patients with resectable gastric cancer. Am J Surg. 2001;181:16–9.PubMedCrossRef
26.
Zurück zum Zitat Ohtsuka T, Nakafusa Y, Sato S, Kitajima Y, Tanaka M, Miyazaki K. Different roles of tumor marker monitoring after curative resections of gastric and colorectal cancers. Dig Dis Sci. 2008;53:1537–43.PubMedCrossRef Ohtsuka T, Nakafusa Y, Sato S, Kitajima Y, Tanaka M, Miyazaki K. Different roles of tumor marker monitoring after curative resections of gastric and colorectal cancers. Dig Dis Sci. 2008;53:1537–43.PubMedCrossRef
27.
Zurück zum Zitat Takahashi Y, Takeuchi T, Sakamoto J, et al; Tumor Marker Committee. The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study. Gastric Cancer. 2003;6:142–5.PubMedCrossRef Takahashi Y, Takeuchi T, Sakamoto J, et al; Tumor Marker Committee. The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study. Gastric Cancer. 2003;6:142–5.PubMedCrossRef
28.
Zurück zum Zitat Tas F, Faruk Aykan N, Aydiner A, Yasasever V, Topuz E. Measurement of serum CA 19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancer. Am J Clin Oncol. 2001;24:148–9.PubMedCrossRef Tas F, Faruk Aykan N, Aydiner A, Yasasever V, Topuz E. Measurement of serum CA 19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancer. Am J Clin Oncol. 2001;24:148–9.PubMedCrossRef
29.
Zurück zum Zitat Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation, National Research Council. Health risks from exposure to low levels of ionizing radiation: BEIR VII. Washington, DC: National Academy of Sciences; 2005. Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation, National Research Council. Health risks from exposure to low levels of ionizing radiation: BEIR VII. Washington, DC: National Academy of Sciences; 2005.
30.
Zurück zum Zitat International Commission on Radiological Protection. The 2007 recommendations of the International Commission on Radiological Protection. New York: International Commission on Radiological Protection; 2007. ICRP publication 103. International Commission on Radiological Protection. The 2007 recommendations of the International Commission on Radiological Protection. New York: International Commission on Radiological Protection; 2007. ICRP publication 103.
31.
Zurück zum Zitat Yoo SY, Kim KW, Han JK, Kim AY, Lee HJ, Choi BI. Helical CT of postoperative patients with gastric carcinoma: value in evaluating surgical complications and tumor recurrence. Abdom Imaging. 2003;28:617–23.PubMedCrossRef Yoo SY, Kim KW, Han JK, Kim AY, Lee HJ, Choi BI. Helical CT of postoperative patients with gastric carcinoma: value in evaluating surgical complications and tumor recurrence. Abdom Imaging. 2003;28:617–23.PubMedCrossRef
32.
Zurück zum Zitat Jadvar H, Tatlidil R, Garcia AA, Conti PS. Evaluation of recurrent gastric malignancy with [F-18]-FDG positron emission tomography. Clin Radiol. 2003;58:215–21.PubMedCrossRef Jadvar H, Tatlidil R, Garcia AA, Conti PS. Evaluation of recurrent gastric malignancy with [F-18]-FDG positron emission tomography. Clin Radiol. 2003;58:215–21.PubMedCrossRef
33.
Zurück zum Zitat Sun L, Su XH, Guan YS, et al. Clinical role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in post-operative follow up of gastric cancer: initial results. World J Gastroenterol. 2008;14:4627–32.PubMedCentralPubMedCrossRef Sun L, Su XH, Guan YS, et al. Clinical role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in post-operative follow up of gastric cancer: initial results. World J Gastroenterol. 2008;14:4627–32.PubMedCentralPubMedCrossRef
34.
Zurück zum Zitat Takeyoshi I, Ohwada S, Ogawa T, et al. The resection of non-hepatic intraabdominal recurrence of gastric cancer. Hepatogastroenterology. 2000;47:1479–81.PubMed Takeyoshi I, Ohwada S, Ogawa T, et al. The resection of non-hepatic intraabdominal recurrence of gastric cancer. Hepatogastroenterology. 2000;47:1479–81.PubMed
35.
Zurück zum Zitat Sakamoto Y, Ohyama S, Yamamoto J, et al. Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients. Surgery. 2003;133:507–11.PubMedCrossRef Sakamoto Y, Ohyama S, Yamamoto J, et al. Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients. Surgery. 2003;133:507–11.PubMedCrossRef
37.
Zurück zum Zitat Tiberio GA, Coniglio A, Marchet A, et al. Metachronous hepatic metastases from gastric carcinoma: a multicentric survey. Eur J Surg Oncol. 2009;35:486–91.PubMedCrossRef Tiberio GA, Coniglio A, Marchet A, et al. Metachronous hepatic metastases from gastric carcinoma: a multicentric survey. Eur J Surg Oncol. 2009;35:486–91.PubMedCrossRef
38.
Zurück zum Zitat de Liano AD, Yarnoz C, Aguilar R, Artieda C, Ortiz H. Surgical treatment of recurrent gastric cancer. Gastric Cancer. 2008;11:10–4.PubMedCrossRef de Liano AD, Yarnoz C, Aguilar R, Artieda C, Ortiz H. Surgical treatment of recurrent gastric cancer. Gastric Cancer. 2008;11:10–4.PubMedCrossRef
Metadaten
Titel
Follow-Up After Gastrectomy for Cancer: An Appraisal of the Italian Research Group for Gastric Cancer
verfasst von
Gian Luca Baiocchi, MD
Daniele Marrelli, MD
Giuseppe Verlato, MD
Paolo Morgagni, MD
Simone Giacopuzzi, MD
Arianna Coniglio, MD
Alberto Marchet, MD
Fausto Rosa, MD
Michela Giulii Capponi, MD
Alberto Di Leo, MD
Luca Saragoni, MD
Luca Ansaloni, MD
Fabio Pacelli, MD
Donato Nitti, MD
Domenico D’Ugo, MD
Franco Roviello, MD
Guido A. M. Tiberio, MD
Stefano M. Giulini, MD
Giovanni De Manzoni, MD
Publikationsdatum
01.06.2014
Verlag
Springer US
Erschienen in
Annals of Surgical Oncology / Ausgabe 6/2014
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-014-3534-8

Weitere Artikel der Ausgabe 6/2014

Annals of Surgical Oncology 6/2014 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.